356 related articles for article (PubMed ID: 15050913)
1. Focus on hepatocellular carcinoma.
Bruix J; Boix L; Sala M; Llovet JM
Cancer Cell; 2004 Mar; 5(3):215-9. PubMed ID: 15050913
[No Abstract] [Full Text] [Related]
2. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
Jpn J Cancer Res; 1999 Dec; 90(12):inside front cover. PubMed ID: 10665642
[No Abstract] [Full Text] [Related]
3. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Genda T; Mizokami M; Ueda R; Hirohashi S
Jpn J Cancer Res; 1999 Dec; 90(12):1301-9. PubMed ID: 10665646
[TBL] [Abstract][Full Text] [Related]
5. Expression of beta-catenin in hepatocellular carcinoma.
Tien LT; Ito M; Nakao M; Niino D; Serik M; Nakashima M; Wen CY; Yatsuhashi H; Ishibashi H
World J Gastroenterol; 2005 Apr; 11(16):2398-401. PubMed ID: 15832407
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
[TBL] [Abstract][Full Text] [Related]
8. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
9. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
10. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y; Sills RC; Houle CD
Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
[TBL] [Abstract][Full Text] [Related]
11. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma.
Ban KC; Singh H; Krishnan R; Seow HF
Cancer Lett; 2003 Sep; 199(2):201-8. PubMed ID: 12969793
[TBL] [Abstract][Full Text] [Related]
12. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.
Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S
Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000
[TBL] [Abstract][Full Text] [Related]
13. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
[TBL] [Abstract][Full Text] [Related]
14. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
15. Expression of beta-catenin in hepatocellular carcinoma in relation to tumor cell proliferation and cyclin D1 expression.
Joo M; Lee HK; Kang YK
J Korean Med Sci; 2003 Apr; 18(2):211-7. PubMed ID: 12692418
[TBL] [Abstract][Full Text] [Related]
16. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in hepatocellular adenomas.
Bioulac-Sage P; Laurent-Puig P; Balabaud C; Zucman-Rossi J
Hepatology; 2003 Feb; 37(2):480; author reply 480-1. PubMed ID: 12540806
[No Abstract] [Full Text] [Related]
18. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
19. [beta-catenin].
Ogawa K; Yaginuma Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():161-6. PubMed ID: 11761935
[No Abstract] [Full Text] [Related]
20. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
